Final answer:
The problem with Glargine (long-duration) and Lispro (rapid-acting) is that they can both cause hypoglycemia, which is a condition characterized by low blood glucose levels.
Step-by-step explanation:
The problem with Glargine (long-duration) and Lispro (rapid-acting) is that they can both cause hypoglycemia, which is a condition characterized by low blood glucose levels. Glargine is a long-acting insulin that helps to regulate blood sugar levels throughout the day, but if too much is taken or if the person's diet or exercise patterns change, it can cause blood sugar to drop too low. Lispro is a rapid-acting insulin that is used to control blood sugar levels during meals, but if the timing of the injection is off or if the person eats less than they anticipated, it can lead to a drop in blood sugar levels.